449 discretionary purchase filings by 288 insiders across 173 Healthcare companies in the last 90 days, totalling $794.0M. Scheduled 10b5-1 plan buys, compensation grants and option exercises are excluded.
| Company | Value | |||
|---|---|---|---|---|
| MLPT MapLight Therapeutics, Inc. Catalyst4, Inc. · 10% | 10% | $50.1M | 2026-08-14 | 2026-08-18 |
| LYCA Lycia Therapeutics, Inc. Bong Y. Koh · 10% | 10% | $35.0M | 2026-10-26 | 2026-10-27 |
| BRVE Braveheart Bio, Inc. Forbion Growth Opportunities Fund III Cooperatief U.A. · 10% | 10% | $34.6M | 2026-08-07 | 2026-08-07 |
| BRVE Braveheart Bio, Inc. Forbion Growth Opportunities Fund III Cooperatief U.A. · 10% | 10% | $30.2M | 2026-08-07 | 2026-08-07 |
| BRVE Braveheart Bio, Inc. Erez Chimovits · Dir, 10% | Dir, 10% | $30.0M | 2026-08-07 | 2026-08-11 |
| BRVE Braveheart Bio, Inc. Orbimed Advisors LLC · Dir, 10% | Dir, 10% | $30.0M | 2026-08-07 | 2026-08-11 |
| KOD Kodiak Sciences Inc. Baker Bros. Advisors (GP) LLC · Dir, 10% | Dir, 10% | $20.2M | 2026-09-28 | 2026-09-30 |
| RAPP Rapport Therapeutics, Inc. Cheryl Gault · Dir | Dir | $20.0M | 2026-10-28 | 2026-10-30 |
| BRVE Braveheart Bio, Inc. AH Bio Fund IV, L.P. · 10% | 10% | $19.8M | 2026-08-07 | 2026-08-11 |
| KOD Kodiak Sciences Inc. Baker Bros. Advisors (GP) LLC · Dir, 10% | Dir, 10% | $17.7M | 2026-09-28 | 2026-09-30 |
| ZNTL Zentalis Pharmaceuticals, Inc. Walters GROUP · 10% | 10% | $15.2M | 2026-08-14 | 2026-08-19 |
| ETRA Electra Therapeutics, Inc. Orbimed Advisors LLC · Dir, 10% | Dir, 10% | $15.0M | 2026-09-21 | 2026-09-23 |
| ETRA Electra Therapeutics, Inc. Carl L. Gordon · Dir, 10% | Dir, 10% | $15.0M | 2026-09-21 | 2026-09-23 |
| IAM Iambic Therapeutics, Inc. Evan Lockwood Rachlin · Dir | Dir | $11.5M | 2026-10-16 | 2026-10-19 |
| KOD Kodiak Sciences Inc. Baker Bros. Advisors (GP) LLC · Dir, 10% | Dir, 10% | $10.4M | 2026-09-28 | 2026-09-30 |
| ADRX ADARx Pharmaceuticals, Inc. SR ONE Capital Management, LLC · 10% | 10% | $10.1M | 2026-09-28 | 2026-09-29 |
| ADRX ADARx Pharmaceuticals, Inc. Simeon George · Dir, 10% | Dir, 10% | $10.1M | 2026-09-28 | 2026-09-29 |
| BLSM BlossomHill Therapeutics, Inc. Orbimed Advisors LLC · Dir | Dir | $10.0M | 2026-08-10 | 2026-08-12 |
| BLSM BlossomHill Therapeutics, Inc. Carl L. Gordon · Dir | Dir | $10.0M | 2026-08-10 | 2026-08-12 |
| ADRX ADARx Pharmaceuticals, Inc. Simeon George · Dir, 10% | Dir, 10% | $10.0M | 2026-09-28 | 2026-09-30 |
Ranked by value purchased in the window, not by past performance. Each insider’s track record is on their profile.